Yang Kaixin, Xiao Yinan, Zhong Linghui, Zhang Wenyang, Wang Peng, Ren Yaru, Shi Lei
RNA Oncology Group, School of Public Health, Lanzhou University, Lanzhou, 730000, People's Republic of China.
College of Animal Science and Technology, Hebei North University, Zhangjiakou, 075131, People's Republic of China.
Cancer Gene Ther. 2023 Nov;30(11):1456-1470. doi: 10.1038/s41417-023-00662-7. Epub 2023 Sep 7.
Long non-coding RNAs (lncRNAs) have been identified as master gene regulators through various mechanisms such as transcription, translation, protein modification and RNA-protein complexes. LncRNA dysregulation is frequently associated with a variety of biological functions and human diseases including cancer. The p53 network is a key tumor-suppressive mechanism that transcriptionally activates target genes to suppress cellular proliferation in human malignancies. Recent research indicates that lncRNAs play an important role in the p53 signaling pathway. In this review, we summarize the current knowledge of lncRNAs in p53-relevant functions and provide an overview of how these altered lncRNAs contribute to tumor initiation and progression. We also discuss the association between lncRNA and up- or downstream genes of p53. These findings imply that lncRNAs can help identify cellular vulnerabilities that may prove to be promising potential biomarkers and therapeutic targets for cancer treatment.
长链非编码RNA(lncRNAs)已被确定为通过转录、翻译、蛋白质修饰和RNA-蛋白质复合物等多种机制发挥作用的主要基因调控因子。LncRNA失调常常与包括癌症在内的多种生物学功能和人类疾病相关。p53网络是一种关键的肿瘤抑制机制,可通过转录激活靶基因来抑制人类恶性肿瘤中的细胞增殖。最近的研究表明,lncRNAs在p53信号通路中发挥重要作用。在本综述中,我们总结了目前关于lncRNAs在p53相关功能方面的知识,并概述了这些改变的lncRNAs如何促进肿瘤的发生和发展。我们还讨论了lncRNA与p53上下游基因之间的关联。这些发现表明,lncRNAs有助于识别细胞中的脆弱点,这些脆弱点可能成为有前景的潜在生物标志物和癌症治疗的靶点。